David Alan Campbell, President and CEO: Janux Therapeutics JANX Sell · Filed 24/12/27

Trade details

Type: Insider sale
Amount: $1,404,750
Shares · price: 25,000 sh · $56.19 a share
Held after: 217,054 sh
Stock: Janux Therapeutics JANX
Person: David Alan CampbellPresident and CEO
Trade date: 24/12/24
Filed: 24/12/27
Days to filing: 3 days

Sold 10.3% of holdings

Share of holding sold: 10.3%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/24~25/01/23

David Alan Campbell's recent trades

David Alan CampbellPresident and CEO
SellJanux Therapeutics
Sell
Janux Therapeutics
JANX
$110.8K
8,072 sh
$110.8K
Filed 01/02
Traded 01/02
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/08
Traded 25/01/07
David Alan CampbellOfficer
Planned sale10b5-1 planJanux Therapeutics
Planned sale10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/07
Traded 25/01/07
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$1M
15,000 sh
$1M
Filed 24/12/03
Traded 24/12/03
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$940.2K
18,281 sh
$940.2K
Filed 24/11/27
Traded 24/11/25